An affiliate company of DFB Pharmaceuticals Inc, Healthpoint, Ltd., has signed an exclusive agreement with IsoTis, S.A. to develop and license its patented, biologic, wound-healing technology called Allox.
Mobile Health Technologies In Studies of Actinic Keratosis Do Not Compromise Patient Safety, Research Article Says
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Introducing Omar Noor, MD, FAAD: Dermatology Times' Newest Editorial Advisory Board Member
ReV Up Your Vitiligo Treatment Strategies
Variable-Sequenced Large-Spot KTP and PDL Demonstrate Comparable Efficacy in Rosacea
Guselkumab Demonstrates Significant Improvement in Psoriasis Symptoms and HRQoL, Reduces Sexual Impairment and Stigmatization